EpiPen Maker Mylan Pharma Expands March Recall of Auto-Injectors

The EpiPen's being recalled were distributed between December 2015 and July 2016 and includes the EpiPen Jr.in the United States. Mylan's new generic EpiPen is not part of the voluntary recall and has been deemed a suitable replacement for the potentially defective product.

The EpiPen 0.3 mg has an expiry date of May 2017 and lot number 5GU763.

EpiPens deliver an emergency dose of adrenaline to people at risk of a serious allergic reaction. These reactions, of course, can be fatal if left untreated and, which makes the EpiPen product special and very important.

Mylan is already suffering from bad PR after the company introduced a 600 percent price hike for the life saving device previous year, an increase the CEO argued was "fair".

The Food and Drug Administration has issued a recall of 13 lots of EpiPen and EpiPen Jr. due to a potential defect.

Consumers who have EpiPens made other than those dates do not need to replace it before its expiration.

Mylan NV announced Friday that more than a dozen lots of its EpiPen and EpiPen Jr.

The defect makes it hard for the EpiPen to work during an emergency and could have significant health consequences for someone who is experiencing an allergic reaction.

List of recalled products from Mylan.

Mylan advised consumers to use their current EpiPens, if needed, until they receive a replacement.